Assessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PET
- Conditions
- CancerRadiotherapyPositron Emission TomographyRadioembolization
- Interventions
- Diagnostic Test: 18F-Fluoromisonidazole PET
- Registration Number
- NCT06027021
- Lead Sponsor
- Ankara University
- Brief Summary
Hypoxia is a known factor for resistance to radiotherapy in tumors. Response to transarterial radioembolization is known to be variable between different patients even if the same dose of radiation was delivered. In this study the investigators aim to quantify the hypoxia in the primary and secondary tumors of liver with 18F-FMISO PET before radioembolization and to prove any effect of the hypoxia, if present, on the dose that should be delivered to tumor to ensure treatment response.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 64
- Diagnosed with colorectal carcinoma with liver metastasis or hepatocellular carcinoma.
- Is not eligible for surgery
- Above 18 years old
- The patients who are referred for transarterial radioembolization treatment to Ankara University School of Medicine Department of Nuclear Medicine.
- Patients with ECOG performance score >1
- Claustrophobia
- Life expectancy shorter than 3 months
- Pregnant or breast-feeding patients
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Treatment group 18F-Fluoromisonidazole PET Patients received radioembolization with hepatocellular cancer or colorectal cancer liver metastases
- Primary Outcome Measures
Name Time Method Demonstrate the effect of the hypoxia in the success of the radioembolization treatment 08/2024 Demonstrate the effect of the hypoxia in the success of the radioembolization treatment
The effect of the hypoxia on the dose-response relationships and required doses to achieve treatment response in the hypoxic and non-hypoxic group. 08/2024 The effect of the hypoxia on the dose-response relationships and required doses to achieve treatment response in the hypoxic and non-hypoxic group.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ankara University
🇹🇷Ankara, Turkey